Number
|
19
|
17
|
Female, (%)
|
5 (26.3)
|
6 (35.3)
|
Age at diagnosis, median (IQR)
|
61.6 (51–65)
|
58 (39–64)
|
Symptoms to MTX, median months (IQR)
|
6.0 (2.2–7.3)
| |
RF (%)
|
11 (57.9)
| |
ACPA (%)
|
11 (57.9)
| |
Erosive arthritis (%)
|
2 (10.5)
| |
Smoking (%)
|
8 (42.1)
| |
Methylprednisolone, median mg/day (IQR)
|
4 (4–8)
| |
Metothrexate, median mg/week (IQR)
|
10 (10–10)
| |
CRP (mg/L), median (IQR)
| | |
Baseline
|
15.3 (3.9–23.2)
| |
1 month
|
5.2 (1.2–9.4)
| |
ESR, median (IQR)
| | |
Baseline
|
28.0 (6.0–38.0)
| |
1 month
|
14.0 (6.5–24.0)
| |
DAS28, mean ± SD
| | |
Baseline
|
4.6 ± 1.6
| |
1 month
|
3.2 ± 1.5
| |